The US FDA has authorized the first prescription COVID-19 molecular test that can be performed entirely at-home. The test fits into the palm of your hand and uses real-time LAMP technology to give a result in just 11 minutes. 
Find Out More

The ECDC has revised its recommendations for rapid antigen testing in a new document that provides independent evaluations of several rapid antigen tests on the market along with requirements labs must adhere to. 
Find Out More

Cytiva (Formerly GE Healthcare) has started a new diagnostic test development and support service for point-of-care diagnostic developers to increase speed to market of new tests through infrastructure, expertise and consultation for immunoassay development.
Find Out More

A new clinical diagnostic test that measures the T-cell response in SARS-CoV-2 infected individuals that can provide a complete picture of the duration of immunity to the virus following an infection or administration of a vaccine will be released this fall. 
Find Out More

Tata Group has begun distributing its Feluda COVID-19 test to labs across India. The CRISPR-based test utilizes a specially adapted Cas9 protein transcription, and a result is read on a dipstick placed into the CRISPR mixture after amplification of the viral material. 
Find Out More

Sino Biological has launched a recombinant Y453F RBD protein, the mutation in SARS-CoV-2 that infected mink and workers at a farm in Denmark recently. This protein adds to Sino's large collection of proteins for antibody and vaccine research. 
Find Out More